Investing.com - Edwards Lifesciences (NYSE:EW) reported first quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $1.32 on revenue of $993M. Analysts polled by Investing.com expected EPS of $1.22 on revenue of $989.24M. That compared to EPS of $1.22 on revenue of $937.5M in the same period a year earlier. The company had reported EPS of $1.17 on revenue of $982.7M in the previous quarter.
Edwards Lifesciences shares lost 0.01% to trade at $180.97 in after-hours trade following the report.
Edwards Lifesciences shares lost 0.01% to trade at $180.97 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are up 18.16%, broadly in line with the S&P 500 which is up 18.44% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On Tuesday, April 16, 2019, J&J reported first quarter EPS of $2.1 on revenue of $20.02B, compared to forecasts of EPS of $2.04 on revenue of $19.61B.
Abbott Labs earnings beat analyst's expectations on Wednesday, April 17, 2019, with first quarter EPS of $0.63 on revenue of $7.37B. Investing.com analysts expected EPS of $0.61 on revenue of $7.48B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar